We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$22.7B
AUM Growth
+$6.91B
(+44%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
20.03%
Top 10 Holdings %
Top 10 Hldgs %
42.56%
Holding
3,800
New
1,351
Increased
647
Reduced
509
Closed
1,292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.95B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$848M |
| 3 |
Applovin
APP
|
+$243M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$142M |
| 5 |
Thomson Reuters
TRI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$443M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$430M |
| 3 |
Shopify
SHOP
|
+$320M |
| 4 |
Flutter Entertainment
FLUT
|
+$240M |
| 5 |
Gilead Sciences
GILD
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.27% |
| 2 | Industrials | 7.89% |
| 3 | Technology | 6.89% |
| 4 | Healthcare | 4.69% |
| 5 | Communication Services | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIYA
2351
Baiya International Group Inc Class A Ordinary Shares
BIYA
$12M
| $35K | ﹤0.01% |
193
+126
| +188% | +$109K |
|
2352
AEON Biopharma
AEON
$13.5M
| $34K | ﹤0.01% |
+45,258
| New | +$26K |
|
2353
InflaRx
IFRX
$271M
| $34K | ﹤0.01% |
43,530
+32,806
| +306% | +$38.8K |
|
2354
Jiuzi Holdings
JZXN
$790K
| $33K | ﹤0.01% |
+879
| New | +$115K |
|
2355
Neumora Therapeutics
NMRA
$302M
| $33K | ﹤0.01% |
+45,064
| New | +$34.1K |
|
2356
Zura Bio
ZURA
$566M
| $33K | ﹤0.01% |
+32,195
| New | +$38.5K |
|
|
MDCX
2357
Medicus Pharma
MDCX
$17M
| $33K | ﹤0.01% |
+11,099
| New | +$44.3K |
|
|
DHY
2358
Credit Suisse High Yield Credit Fund
DHY
$240M
| $32K | ﹤0.01% |
15,387
-70,655
| -82% | -$144K |
|
2359
ParaZero Technologies
PRZO
$14.4M
| $31K | ﹤0.01% |
25,531
+10,564
| +71% | +$9.36K |
|
2360
American Resources Corp
AREC
$293M
| $30K | ﹤0.01% |
36,229
+23,433
| +183% | +$18.8K |
|
|
STAK
2361
STAK Inc
STAK
$32.7M
| $29K | ﹤0.01% |
+16,360
| New | +$34.5K |
|
|
SAGT
2362
Sagtec Global
SAGT
$14.3M
| $29K | ﹤0.01% |
+13,358
| New | +$40.9K |
|
2363
China Pharma Holdings
CPHI
$45.8M
| $28K | ﹤0.01% |
16,168
+13,657
| +544% | +$25.1K |
|
2364
Rafael Holdings
RFL
$107M
| $28K | ﹤0.01% |
+16,365
| New | +$26.7K |
|
|
DCOY
2365
Decoy Therapeutics
DCOY
$2.09M
| $28K | ﹤0.01% |
+176
| New | +$24.8K |
|
|
NIPG
2366
NIP Group Inc
NIPG
$67.4M
| $28K | ﹤0.01% |
+382
| New | +$18.4K |
|
|
MRSN
2367
DELISTED
Mersana Therapeutics
MRSN
| $27K | ﹤0.01% |
3,735
+1,875
| +101% | +$16.5K |
|
2368
Roadzen
RDZN
$112M
| $27K | ﹤0.01% |
+27,955
| New | +$28K |
|
2369
RenovoRx
RNXT
$50.5M
| $27K | ﹤0.01% |
+20,632
| New | +$23.5K |
|
2370
SES AI
SES
$208M
| $27K | ﹤0.01% |
+31,124
| New | +$26.1K |
|
|
BOLD
2371
Boundless Bio
BOLD
$65M
| $27K | ﹤0.01% |
+27,509
| New | +$36.5K |
|
|
ZONE
2372
CleanCore Solutions
ZONE
$81.5M
| $27K | ﹤0.01% |
+11,444
| New | +$23.1K |
|
|
AMOD
2373
Alpha Modus Holdings
AMOD
$22.1M
| $27K | ﹤0.01% |
604
+209
| +53% | +$10.4K |
|
2374
Heartbeam
BEAT
$29.1M
| $26K | ﹤0.01% |
+20,851
| New | +$34.6K |
|
2375
Loop Industries
LOOP
$32.9M
| $26K | ﹤0.01% |
+18,796
| New | +$22.7K |
|
Similar funds
DB
HRT Financial's Q2 2025 Portfolio in Review
As of Q2 2025, HRT Financial held 3,800 positions worth $22.7B, up 44% from $15.8B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
HRT Financial deployed $4.55B of net new capital in Q2 2025, opening 1,351 new positions and adding to 647 existing holdings. Its largest new stake was The AZEK Co: 2,834,659 shares worth $154M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.3% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $430M trimmed.
- HRT Financial's largest Q2 2025 buy was The AZEK Co: 2,834,659 shares worth $154M.
- HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.95B increase.
- HRT Financial's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $430M.
- HRT Financial fully exited Broadcom in Q2 2025, selling an estimated $443M.
- HRT Financial's ten largest holdings make up 43% of its $22.7B portfolio in Q2 2025.
- HRT Financial opened 1,351 new positions and closed 1,292 in Q2 2025.
- HRT Financial's portfolio value rose 44% quarter-over-quarter to $22.7B.
Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.